Pages that link to "Q80651418"
Jump to navigation
Jump to search
The following pages link to Preclinical studies in rats and squirrel monkeys for safety evaluation of the bivalent anti-human T cell immunotoxin, A-dmDT390-bisFv(UCHT1) (Q80651418):
Displaying 8 items.
- Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Cutaneous T-cell lymphomas (Q26774768) (← links)
- Treatment of hematologic malignancies with immunotoxins and antibody-drug conjugates (Q35446333) (← links)
- Resimmune, an anti-CD3ε recombinant immunotoxin, induces durable remissions in patients with cutaneous T-cell lymphoma (Q35669880) (← links)
- An anti-PSMA bivalent immunotoxin exhibits specificity and efficacy for prostate cancer imaging and therapy (Q37090589) (← links)
- Recombinant immunotoxins for the treatment of chemoresistant hematologic malignancies. (Q37581788) (← links)
- Effect of pre-existing anti-diphtheria toxin antibodies on T cell depletion levels following diphtheria toxin-based recombinant anti-monkey CD3 immunotoxin treatment (Q41840686) (← links)
- Dosing optimization of CCR4 immunotoxin for improved depletion of CCR4+ Treg in nonhuman primates (Q89005419) (← links)
- Monolith affinity chromatography for the rapid quantification of a single-chain variable fragment immunotoxin (Q89006410) (← links)